Stay updated on Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial
Sign up to get notified when there's something new on the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page.

Latest updates to the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page
- CheckyesterdayChange DetectedNo significant changes to the study page were observed in the screenshots.SummaryDifference0.1%

- Check8 days agoChange DetectedThe screenshots show no substantive changes to core study details (title, conditions, outcomes, and eligibility). The page appears unchanged.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedMinor site revision updated from v3.2.0 to v3.3.2; this change does not affect study information or participant-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check30 days agoChange DetectedThe page no longer shows the government funding lapse notice for NIH’s operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check37 days agoChange DetectedNo significant changes were observed on the study details page between the two screenshots.SummaryDifference0.1%

- Check44 days agoChange DetectedNo substantive changes to core study content (design, eligibility criteria, enrollment, primary or secondary outcomes, or locations) were observed; the update appears to be metadata such as the last update date. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bardoxolone in CTD-Associated Pulmonary Arterial Hypertension Clinical Trial page.